Universität zu Köln

Journal Article

Moehn, Nora, Grote-Levi, Lea, Hopfner, Franziska ORCID: 0000-0001-6524-0281, Eiz-Vesper, Britta, Maecker-Kolhoff, Britta, Warnke, Clemens ORCID: 0000-0002-3510-9255, Suehs, Kurt-Wolfram, Wattjes, Mike P., Hoeglinger, Guenter U. and Skripuletz, Thomas ORCID: 0000-0001-8550-335X (2022). Innovative therapeutic concepts of progressive multifocal leukoencephalopathy. J. Neurol., 269 (5). S. 2403 - 2414. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1459

Warnke, Clemens, Wijburg, Martijn T., Hartung, Hans-Peter, Killestein, Joep, Adams, Ortwin and Wattjes, Mike P. (2017). Application of the CSF JCV antibody index to early natalizumab-associated progressive multifocal leukoencephalopathy. J. Neurol. Neurosurg. Psychiatry, 88 (12). S. 1092 - 1095. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-330X

Wattjes, Mike P., Wijburg, Martijn T., van Eijk, Jeroen, Frequin, Stephan, Uitdehaag, Bernard M. J., Barkhof, Frederik ORCID: 0000-0003-3543-3706, Warnke, Clemens and Killestein, Joep (2018). Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS. J. Neurol. Neurosurg. Psychiatry, 89 (5). S. 535 - 542. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-330X

Wijburg, Martijn T., Kleerekooper, Iris ORCID: 0000-0001-6456-9034, Lissenberg-Witte, Birgit I., de Vos, Marlieke, Warnke, Clemens, Uitdehaag, Bernard M. J., Barkhof, Frederik ORCID: 0000-0003-3543-3706, Killestein, Joep and Wattjes, Mike P. (2018). Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis. JAMA Neurol., 75 (7). S. 827 - 834. CHICAGO: AMER MEDICAL ASSOC. ISSN 2168-6157

Wijburg, Martijn T., Warnke, Clemens, Barkhof, Frederik ORCID: 0000-0003-3543-3706, Uitdehaag, Bernard M. J., Killestein, Joep and Wattjes, Mike P. (2019). Performance of PML diagnostic criteria in natalizumab-associated PML: data from the Dutch-Belgian cohort. J. Neurol. Neurosurg. Psychiatry, 90 (1). S. 44 - 47. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-330X

Wijburg, Martijn T., Warnke, Clemens, Killestein, Joep and Wattjes, Mike P. (2020). Application of Mentzer's PML case definition to natalizumab-treated patients in the setting of strict MRI-based pharmacovigilance. J. Neurol., 267 (9). S. 2599 - 2603. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1459

Wijburg, Martijn T., Warnke, Clemens ORCID: 0000-0002-3510-9255, McGuigan, Christopher, Koralnik, Igor J., Barkhof, Frederik ORCID: 0000-0003-3543-3706, Killestein, Joep and Wattjes, Mike P. (2021). Pharmacovigilance during treatment of multiple sclerosis: early recognition of CNS complications. J. Neurol. Neurosurg. Psychiatry, 92 (2). S. 177 - 189. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-330X

van Maurik, Ingrid S., Slot, Rosalinde E. R., Verfaillie, Sander C. J., Zwan, Marissa D., Bouwman, Femke H., Prins, Niels D., Teunissen, Charlotte E., Scheltens, Philip ORCID: 0000-0002-1046-6408, Barkhof, Frederik ORCID: 0000-0003-3543-3706, Wattjes, Mike P., Molinuevo, Jose Luis, Rami, Lorena, Wolfsgruber, Steffen, Peters, Oliver, Jessen, Frank, Berkhof, Johannes and van der Flier, Wiesje M. (2019). Personalized risk for clinical progression in cognitively normal subjects-the ABIDE project. Alzheimers Res. Ther., 11. LONDON: BMC. ISSN 1758-9193